All posts by GTCbio


Overcoming challenges of clinical validation and translation of Biomarkers

GTCbio | March 6th, 2017

Various types of biomarkers are being developed to help with decision-making in drug-development and clinical practice. However, several challenges remain in understanding the clinical and economic drivers of biomarkers.  According to National Biomarker Development Alliance, the key requirement for biomarker validation is that it has to serve as a surrogate endpoint in a clinical trial….read more